Haoxi Health Technology Limited Announces the Closing of a $12 Million Underwritten Follow-on Public Offering
20 Setembro 2024 - 5:05PM
Haoxi Health Technology Limited (the “Company” or “HAO”), an online
marketing solution provider headquartered in Beijing, China, today
announced that it closed its previously announced underwritten
follow-on offering of 4,000,000 units (each a “Unit,” and
collectively, the “Units”) at a public offering price of $3.00 per
Unit (the “Offering”). Each Unit consists of (i) one share of Class
A Ordinary Share, par value $0.0001 per share (the “Class A
Ordinary Share”) (or one pre-funded warrant to purchase one Class A
Ordinary Share (the “Pre-Funded Warrant”)), (ii) one Series A
warrant to purchase one Class A Ordinary Share (the “Series A
Warrant”) initially, but five Class A Ordinary Shares on and after
the Series B Exercise Date, and (iii) one Series B warrant to
purchase four of Class A Ordinary Shares on and after the sixteenth
(16th) calendar day (the “Series B Exercise Date”) following the
closing of the Offering (the "Series B Warrant”, together with the
Series A Warrant, the “Warrants”). The Units have no stand-alone
rights and therefore are not certificated or issued as stand-alone
securities. The Class A Ordinary Shares and related Warrants are
issued separately in the Offering. The Company received aggregate
gross proceeds of $12,000,000 from the Offering, before deducting
underwriting discounts and other offering expenses, excluding the
exercise of any Warrants.
The Offering has been conducted on a firm
commitment basis. The Company has granted EF Hutton LLC (“EF
Hutton”), the underwriter, an option, within 45 days from the
closing date, to purchase up to an additional 600,000 Units at the
public offering price, less underwriting discounts, to cover the
over-allotment.
EF Hutton is acting as the sole bookrunner for
the Offering. Hunter Taubman Fischer & Li LLC is acting as U.S.
counsel to the Company, and Pryor Cashman LLP is acting as U.S.
counsel to EF Hutton, in connection with the Offering.
“We are pleased to close this offering and
appreciate the continued support and market recognition as we
execute our business plan” said Mr. Zhen Fan, Chairman and CEO of
HAO. “The proceeds provided by this offering will help facilitate
our continued business expansion and technologies investment in
healthcare industry.”
The registration statement on Form F-1 (File No.
333-280174) relating to the Offering, as amended, was filed with
the U.S. Securities and Exchange Commission (the "SEC"), and was
declared effective by the SEC on September 19, 2024. The Offering
is being made only by means of a prospectus. Copies of the final
prospectus related to the Offering may be obtained, from EF Hutton,
Attn: Syndicate Department, 590 Madison Avenue, 39th Floor, New
York, NY 10022, or via email at syndicate@efhutton.com or telephone
at (212) 404-7002. In addition, a copy of the final prospectus can
also be obtained via the SEC’s website at www.sec.gov.
This press release shall not constitute an offer
to sell or the solicitation of an offer to buy the securities
described herein, nor shall there be any sale of these securities
in any state or jurisdiction in which such offer, solicitation, or
sale would be unlawful prior to registration or qualification under
the securities laws of any such state or jurisdiction.
About Haoxi Health Technology
Limited
Haoxi Health Technology Limited is a
Beijing-headquartered online marketing solution provider in China,
specializing in serving healthcare industry advertiser clients. The
Company’s growth is driven by the rise of news feed ads and the
rapid development of the healthcare sector. The Company offers
one-stop online marketing solutions, especially in online short
video marketing, helping advertisers acquire and retain customers
on popular platforms in China, such as Toutiao, Douyin, WeChat, and
Sina Weibo. It is dedicated to reducing costs, increasing
efficiency, and providing easy online marketing solutions to
advertisers. For more information, please visit:
http://ir.haoximedia.com.
Forward-Looking Statement
This press release contains forward-looking
statements. Forward-looking statements include statements
concerning plans, objectives, goals, strategies, future events or
performance, and underlying assumptions and other statements that
are other than statements of historical facts. When the Company
uses words such as "may", "will", "intend," "should," "believe,"
"expect," "anticipate," "project," "estimate" or similar
expressions that do not relate solely to historical matters, it is
making forward-looking statements. These forward-looking statements
include, without limitation, the Company's statements regarding the
expected trading of its Ordinary Shares on the Nasdaq Capital
Market and the closing of the Offering. Forward-looking statements
are not guarantees of future performance and involve risks and
uncertainties that may cause the actual results to differ
materially from the Company's expectations discussed in the
forward-looking statements. These statements are subject to
uncertainties and risks including, but not limited to, the
uncertainties related to market conditions and the completion of
the initial public offering on the anticipated terms or at all, and
other factors discussed in the “Risk Factors” section of the
registration statement filed with the SEC. For these reasons, among
others, investors are cautioned not to place undue reliance upon
any forward-looking statements in this press release. Additional
factors are discussed in the Company's filings with the SEC, which
are available for review at www.sec.gov. The Company undertakes no
obligation to publicly revise these forward-looking statements to
reflect events or circumstances that arise after the date
hereof.
For more information, please
contact:
UnderwriterEF Hutton LLCMs. Stephanie Hu, Head
of Asia, Investment BankingEmail:
syndicate@efhutton.com
Investor RelationsWFS Investor Relations
Inc.Janice Wang, Managing PartnerEmail:
services@wealthfsllc.comPhone: +86 13811768599+1 628 283 9214
Haoxi Health Technology (NASDAQ:HAO)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024
Haoxi Health Technology (NASDAQ:HAO)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024